Market Closed -
Nasdaq
21:00:00 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
27.01
USD
|
+1.47%
|
|
+2.58%
|
-38.60%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
763.4
|
1,966
|
2,076
|
1,269
|
624.1
|
383.8
|
-
|
-
|
Enterprise Value (EV)
1 |
702.4
|
1,966
|
2,918
|
2,234
|
1,761
|
1,453
|
1,406
|
1,333
|
P/E ratio
|
-228
x
|
58.5
x
|
-316
x
|
-39.7
x
|
-3.05
x
|
-13.5
x
|
41.3
x
|
16.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.51
x
|
1.44
x
|
1.04
x
|
0.51
x
|
0.23
x
|
0.13
x
|
0.13
x
|
0.12
x
|
EV / Revenue
|
0.47
x
|
1.44
x
|
1.46
x
|
0.89
x
|
0.64
x
|
0.51
x
|
0.46
x
|
0.41
x
|
EV / EBITDA
|
13.7
x
|
11.6
x
|
14.2
x
|
10.3
x
|
8.85
x
|
7.81
x
|
6.52
x
|
5.5
x
|
EV / FCF
|
14
x
|
5.85
x
|
17.6
x
|
-51.4
x
|
-14.1
x
|
43.1
x
|
20.8
x
|
13.4
x
|
FCF Yield
|
7.13%
|
17.1%
|
5.67%
|
-1.95%
|
-7.11%
|
2.32%
|
4.81%
|
7.49%
|
Price to Book
|
2.42
x
|
-
|
5.58
x
|
3.58
x
|
3.99
x
|
2.52
x
|
1.88
x
|
1.42
x
|
Nbr of stocks (in thousands)
|
12,899
|
14,184
|
14,000
|
14,138
|
14,187
|
14,211
|
-
|
-
|
Reference price
2 |
59.18
|
138.6
|
148.3
|
89.73
|
43.99
|
27.01
|
27.01
|
27.01
|
Announcement Date
|
27/02/20
|
26/02/21
|
25/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,510
|
1,369
|
1,997
|
2,504
|
2,751
|
2,843
|
3,050
|
3,232
|
EBITDA
1 |
51.22
|
169.3
|
205
|
215.9
|
198.9
|
186
|
215.8
|
242.4
|
EBIT
1 |
24.73
|
123.2
|
89.77
|
57.08
|
-139.9
|
49.89
|
100.4
|
110
|
Operating Margin
|
1.64%
|
9%
|
4.5%
|
2.28%
|
-5.09%
|
1.75%
|
3.29%
|
3.4%
|
Earnings before Tax (EBT)
1 |
-5.526
|
114.4
|
40.69
|
-4.877
|
-209.1
|
-28.73
|
14.56
|
35.11
|
Net income
1 |
-3.437
|
32.47
|
-6.585
|
-31.81
|
-204.5
|
-23.84
|
16.33
|
24.33
|
Net margin
|
-0.23%
|
2.37%
|
-0.33%
|
-1.27%
|
-7.43%
|
-0.84%
|
0.54%
|
0.75%
|
EPS
2 |
-0.2600
|
2.370
|
-0.4700
|
-2.260
|
-14.43
|
-1.995
|
0.6533
|
1.635
|
Free Cash Flow
1 |
50.08
|
336.3
|
165.5
|
-43.45
|
-125.3
|
33.71
|
67.67
|
99.81
|
FCF margin
|
3.32%
|
24.57%
|
8.29%
|
-1.73%
|
-4.55%
|
1.19%
|
2.22%
|
3.09%
|
FCF Conversion (EBITDA)
|
97.78%
|
198.58%
|
80.74%
|
-
|
-
|
18.13%
|
31.36%
|
41.18%
|
FCF Conversion (Net income)
|
-
|
1,035.65%
|
-
|
-
|
-
|
-
|
414.4%
|
410.21%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/02/20
|
26/02/21
|
25/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
575.8
|
574.5
|
628.2
|
647.8
|
653.9
|
662.3
|
699.1
|
686.9
|
702.8
|
684.5
|
701
|
723
|
734.9
|
741.9
|
754
|
EBITDA
1 |
57.51
|
48.83
|
51.66
|
51.8
|
57.83
|
49.38
|
51.42
|
49.64
|
48.49
|
32.14
|
42.43
|
53.52
|
57.88
|
47.62
|
51.86
|
EBIT
1 |
20.26
|
14.87
|
23.15
|
12.45
|
6.617
|
8.098
|
-175.8
|
12.04
|
15.68
|
-3.395
|
10.14
|
19.68
|
23.47
|
9.97
|
20.61
|
Operating Margin
|
3.52%
|
2.59%
|
3.68%
|
1.92%
|
1.01%
|
1.22%
|
-25.14%
|
1.75%
|
2.23%
|
-0.5%
|
1.45%
|
2.72%
|
3.19%
|
1.34%
|
2.73%
|
Earnings before Tax (EBT)
1 |
5.593
|
-0.526
|
7.674
|
-3.11
|
-8.915
|
-7.86
|
-192.7
|
-5.801
|
-2.675
|
-22.08
|
-9.11
|
-0.7448
|
3.214
|
-10.44
|
0.506
|
Net income
1 |
-31.53
|
0.318
|
3.328
|
-28.5
|
-6.947
|
-3.962
|
-190.9
|
-4.302
|
-5.252
|
-22.3
|
-6.219
|
0.485
|
4.052
|
-9.284
|
0.4295
|
Net margin
|
-5.48%
|
0.06%
|
0.53%
|
-4.4%
|
-1.06%
|
-0.6%
|
-27.31%
|
-0.63%
|
-0.75%
|
-3.26%
|
-0.89%
|
0.07%
|
0.55%
|
-1.25%
|
0.06%
|
EPS
2 |
-2.250
|
0.0200
|
0.2400
|
-2.030
|
-0.4900
|
-0.2800
|
-13.47
|
-0.3000
|
-0.3700
|
-1.570
|
-0.5500
|
-0.0550
|
0.1625
|
-0.6400
|
0.0250
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/22
|
05/05/22
|
04/08/22
|
03/11/22
|
23/02/23
|
04/05/23
|
03/08/23
|
02/11/23
|
22/02/24
|
02/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
842
|
965
|
1,137
|
1,069
|
1,022
|
949
|
Net Cash position
1 |
61
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
4.108
x
|
4.468
x
|
5.717
x
|
5.751
x
|
4.738
x
|
3.916
x
|
Free Cash Flow
1 |
50.1
|
336
|
166
|
-43.4
|
-125
|
33.7
|
67.7
|
99.8
|
ROE (net income / shareholders' equity)
|
-
|
-
|
28.6%
|
28.4%
|
31.3%
|
42.4%
|
51.2%
|
49%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
6.5%
|
5.21%
|
4.31%
|
3.68%
|
5.08%
|
6.3%
|
Assets
1 |
-
|
-
|
-101.3
|
-610.8
|
-4,748
|
-647.5
|
321.7
|
386.4
|
Book Value Per Share
2 |
24.50
|
-
|
26.60
|
25.00
|
11.00
|
10.70
|
14.40
|
19.00
|
Cash Flow per Share
2 |
-
|
-
|
13.30
|
-0.7400
|
-5.850
|
4.070
|
6.130
|
7.960
|
Capex
1 |
10.9
|
12.2
|
21.3
|
33
|
42.3
|
33.5
|
39
|
42
|
Capex / Sales
|
0.72%
|
0.89%
|
1.07%
|
1.32%
|
1.54%
|
1.18%
|
1.28%
|
1.3%
|
Announcement Date
|
27/02/20
|
26/02/21
|
25/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Last Close Price
27.01
USD Average target price
43.8
USD Spread / Average Target +62.16% Consensus |
1st Jan change
|
Capi.
|
---|
| -38.60% | 378M | | +18.41% | 83.07B | | -29.08% | 70.89B | | +3.59% | 28.32B | | -7.08% | 17.73B | | +2.07% | 17.43B | | +0.93% | 15.64B | | +6.78% | 13.46B | | +8.40% | 12.82B | | +68.45% | 12.69B |
Other Healthcare Facilities & Services
|